Lactobacillus acidophilus ATCC 4356 attenuates the atherosclerotic progression through modulation of oxidative stress and inflammatory process.
- 2013-09
- International Immunopharmacology 17(1)
- Lihua Chen
- Wenen Liu
- Yan-Ming Li
- San Luo
- Qingxia Liu
- Yi-ming Zhong
- Zi-juan Jian
- Meihua Bao
- PubMed: 23747589
- DOI: 10.1016/j.intimp.2013.05.018
- Low evidence
ApoE(-/-) mice treated with L. acidophilus ATCC 4356 showed ... improvements of gut microbiota distribution, as compared to ApoE(-/-) mice in the vehicle group.
- Effect
- Beneficial
- Effect size
- Moderate